We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-3.29%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$14.7B
AUM Growth
+$1.28B
Cap. Flow
+$2.06B
Cap. Flow %
13.96%
Top 10 Hldgs %
12.95%
Holding
676
New
148
Increased
154
Reduced
125
Closed
204

Top Buys

Rank Stock Value
1
AER icon
AerCap
AER
+$213M
2
ADBE icon
Adobe
ADBE
+$164M
3
ADI icon
Analog Devices
ADI
+$162M
4
PAYC icon
Paycom
PAYC
+$128M
5
CRM icon
Salesforce
CRM
+$116M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$189M
2
NVDA icon
NVIDIA
NVDA
+$169M
3
DLTR icon
Dollar Tree
DLTR
+$148M
4
VRT icon
Vertiv
VRT
+$127M
5
DELL icon
Dell
DELL
+$122M

Sector Composition

Rank Sector Weight
1 Technology 22.19%
2 Consumer Discretionary 15.96%
3 Industrials 14.65%
4 Healthcare 13.59%
5 Financials 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
426
Ametek
AME
$58B
$874K 0.01%
+5,914
New +$924K
HOWL icon
427
Werewolf Therapeutics
HOWL
$18.6M
$851K 0.01%
397,808
BETR icon
428
Better Home & Finance Holding
BETR
$341M
$838K 0.01%
+35,000
New +$26.8M
ANTX icon
429
AN2 Therapeutics
ANTX
$213M
$804K 0.01%
50,000
-48,426
-49% -$548K
NKTR icon
430
Nektar Therapeutics
NKTR
$2.53B
$793K 0.01%
+88,781
New +$855K
MDXH icon
431
MDxHealth
MDXH
$23.3M
$783K 0.01%
279,555
HYPR icon
432
Hyperfine
HYPR
$101M
$769K 0.01%
375,000
SCTL
433
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$749K 0.01%
1,597,931
AXDX
434
DELISTED
Accelerate Diagnostics
AXDX
$712K ﹤0.01%
123,898
-1
-0% -$7
SNCE
435
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$707K ﹤0.01%
88,319
HLVX
436
DELISTED
HilleVax
HLVX
$706K ﹤0.01%
+52,500
New +$739K
MDVL
437
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$698K ﹤0.01%
116,300
-4,001
-3% -$41.1K
OC icon
438
Owens Corning
OC
$12.2B
$686K ﹤0.01%
+5,027
New +$691K
CRBU icon
439
Caribou Biosciences
CRBU
$165M
$598K ﹤0.01%
+125,000
New +$776K
VFF icon
440
CALL
Village Farms International
VFF
$289M
$590K ﹤0.01%
740,000
NMRD
441
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$580K ﹤0.01%
1,842,565
-640,706
-26% -$444K
LXRX icon
442
Lexicon Pharmaceuticals
LXRX
$1.07B
$555K ﹤0.01%
509,484
-1,232,868
-71% -$2.16M
CRMD icon
443
CorMedix
CRMD
$591M
$555K ﹤0.01%
150,000
-850,000
-85% -$3.38M
RYZB
444
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$555K ﹤0.01%
+25,000
New +$525K
CTKB icon
445
Cytek Biosciences
CTKB
$606M
$552K ﹤0.01%
100,000
VBIV
446
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$521K ﹤0.01%
+782,000
New +$958K
MXCT icon
447
MaxCyte
MXCT
$130M
$520K ﹤0.01%
166,630
CRIS icon
448
Curis
CRIS
$7.13M
$515K ﹤0.01%
+3,907
New +$1.01M
LYRA
449
DELISTED
LYRA THERAPEUTICS INC
LYRA
$512K ﹤0.01%
2,617
-7,012
-73% -$1.25M
SLRN
450
DELISTED
ACELYRIN
SLRN
$509K ﹤0.01%
50,070

Similar funds

Alyeska Investment Group's Q3 2023 Portfolio in Review

As of Q3 2023, Alyeska Investment Group held 676 positions worth $14.7B, up 9.5% from $13.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Alyeska Investment Group deployed $2.06B of net new capital in Q3 2023, opening 148 new positions and adding to 154 existing holdings. Its largest new stake was Paycom: 419,219 shares worth $109M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was NVIDIA, an estimated $169M trimmed.

  • Alyeska Investment Group's largest Q3 2023 buy was Paycom: 419,219 shares worth $109M.
  • Alyeska Investment Group added most to AerCap in Q3 2023, an estimated $213M increase.
  • Alyeska Investment Group's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $169M.
  • Alyeska Investment Group fully exited Activision Blizzard in Q3 2023, selling an estimated $189M.
  • Alyeska Investment Group's ten largest holdings make up 13% of its $14.7B portfolio in Q3 2023.
  • Alyeska Investment Group opened 148 new positions and closed 204 in Q3 2023.
  • Alyeska Investment Group's portfolio value rose 9.5% quarter-over-quarter to $14.7B.

Based on Alyeska Investment Group's 13F filing for Q3 2023, filed 14 Nov 2023.